Διοίκηση

Η διοίκηση της LEO Pharma Α/S έχει μια δομή δύο επιπέδων που αποτελείται από την Ηγετική Ομάδα και το Διοικητικό Συμβούλιο. Τα δύο σώματα είναι ανεξάρτητα.

Ηγετική Ομάδα της LEO Pharma Α/S

  • Christophe Bourdon, CEO LEO Pharma

  • Anders Kronborg, Chief Financial Officer, Global Finance and Business Services

  • Guillaume Clément, Executive Vice President, Thrombosis & Special Projects

  • Brian Hilberdink, Executive Vice President, Region North America

  • Becki Morison, Executive Vice President, Global Product Strategy & International Operations

  • Sven Hauptmann, Executive Vice President, Global Product Supply

  • Jörg Möller, Executive Vice President, Global Research & Development

  • Dennis Schmidt Pedersen, Executive Vice President, Global People

 

Διοικητικό Συμβούλιο

Το Διοικητικό Συμβούλιο έχει εποπτικό ρόλο με άμεση μεσολάβηση σε βασικές αποφάσεις για το μέλλον της LEO Pharma.

  • Jesper Brandgaard, Chair, Board Member since 2021

  • Peter Haahr, Board Member since 2021

  • Franck Maréno, Employee elected, Board Member since 2018

  • Jannie Kogsbøll, Employee elected, Board Member since 1998

  • Jan van de Winkel, Board Member since 2017

  • Jesper Mailind, Vice-chair, Board Member since 2018

  • Karin Attermann, Employee elected, Board Member since 2008

  • Signe Maria Christensen, Employee elected, Board Member since 2018

  • Elisabeth Svanberg, Board Member since 2022

  • Lotte Hjortshøj Larsen, Employee elected Board member, Diploma Graduate

  • Lars Green, Board member since 2021